No Data
No Data
DEA Sets Hearing on Cannabis Rescheduling and Delays Decision Until After the Election
Is it Harris' turn to dominate the market? Wall Street is adjusting its bets.
① Harris continued to make great progress in the polls, which directly led to Wall Street ignoring the "Trump trade"; ② Specific industries and stocks in the US stock market have been affected, but overall they are not as strong as the "Trump trade"; ③ Analysts point out that the results of the "Hart" competition are not absolute, and it is not yet time to lock in positions.
Cannabis Stocks Drop as DEA Sets Drug-rescheduling Hearing After November Election
The hearing on the reclassification of cannabis is approaching, and both US cannabis stocks and ETFs are under pressure.
The upcoming open hearing on December 2nd by the US Drug Enforcement Administration has attracted widespread attention from the market, and aims to discuss the proposal to reclassify marijuana.
NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024